The new lingo of added value.
In the vast kit of tools used by corporate America to measure success, one has vaulted from the desks of CFOs to the cover of Fortune. Economic value added, better known as EVA, has become the tool of choice to assess shareholder value in publicly owned companies. Despite its Wall Street roots, advocates say EVA can also be applied to the traditionally not-for-profit health care industry, especially in an age of brutal competition for scarce capital.